69 related articles for article (PubMed ID: 1353333)
1. Subcellular compartmentation of 2'methyl MPP+ can explain differences in toxicity to adrenal chromaffin cells.
Reinhard JF; Daniels AJ
Ann N Y Acad Sci; 1992 May; 648():323-5. PubMed ID: 1353333
[No Abstract] [Full Text] [Related]
2. Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.
Reinhard JF; Diliberto EJ; Viveros OH; Daniels AJ
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8160-4. PubMed ID: 2891137
[TBL] [Abstract][Full Text] [Related]
3. The interaction of 1-methyl-4-phenylpyridinium (MPP+) with bovine adrenal medulla chromaffin vesicle ghosts.
Farmer MK; Tipton KF
Biochem Soc Trans; 1996 Feb; 24(1):60S. PubMed ID: 8674735
[No Abstract] [Full Text] [Related]
4. Mechanisms of toxicity and cellular resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in adrenomedullary chromaffin cell cultures.
Reinhard JF; Carmichael SW; Daniels AJ
J Neurochem; 1990 Jul; 55(1):311-20. PubMed ID: 1972391
[TBL] [Abstract][Full Text] [Related]
5. Carrier-independent entry of 1-methyl-4-phenylpyridinium (MPP+) into adrenal chromaffin cells as a consequence of charge delocalization.
Reinhard JF; Daniels AJ; Painter GR
Biochem Biophys Res Commun; 1990 May; 168(3):1143-8. PubMed ID: 2346481
[TBL] [Abstract][Full Text] [Related]
6. Uptake of the neurotoxin, 4-methylphenylpyridinium, into chromaffin granules and synaptic vesicles: a proton gradient drives its uptake through monoamine transporter.
Moriyama Y; Amakatsu K; Futai M
Arch Biochem Biophys; 1993 Sep; 305(2):271-7. PubMed ID: 8373164
[TBL] [Abstract][Full Text] [Related]
7. Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Staal RG; Yang JM; Hait WN; Sonsalla PK
Brain Res; 2001 Aug; 910(1-2):116-25. PubMed ID: 11489261
[TBL] [Abstract][Full Text] [Related]
8. Acute peripheral catecholaminergic changes in rat after MPTP and MPP+ treatment.
Ambrosio S; Mahy N
Rev Esp Fisiol; 1989 Jun; 45(2):157-61. PubMed ID: 2570448
[TBL] [Abstract][Full Text] [Related]
9. Vesicular monoamine transporter substrate/inhibitor activity of MPTP/MPP+ derivatives: a structure-activity study.
Wimalasena DS; Perera RP; Heyen BJ; Balasooriya IS; Wimalasena K
J Med Chem; 2008 Feb; 51(4):760-8. PubMed ID: 18220329
[TBL] [Abstract][Full Text] [Related]
10. 1-amino-4-phenyl-1,2,3,6-tetrahydropyridine and 1-amino-4-phenylpyridinium salt, the 1-amino analogues of neurotoxins, MPTP and MPP+, induce apoptosis in PC12 cells: detection of apoptotic cells by Comet assay and flow cytometric analysis.
Noda Y; Sumino T; Fujisawa Y; Miyata N; Kaiya T; Kohda K
In Vivo; 2004; 18(5):561-9. PubMed ID: 15523894
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity.
Castagnoli K; Palmer S; Castagnoli N
Neurobiology (Bp); 1999; 7(2):135-49. PubMed ID: 10591048
[TBL] [Abstract][Full Text] [Related]
12. Nicotinic cholinergic regulation of tetrahydrobiopterin levels in bovine adrenal chromaffin cells.
Waymire JC; Ayling JE; Craviso GL
Adv Exp Med Biol; 1993; 338():235-8. PubMed ID: 7905697
[No Abstract] [Full Text] [Related]
13. Reserpine increases opiate-like peptide content and tyrosine hydroxylase activity in adrenal medullary chromaffin cells in culture.
Wilson SP; Abou-Donia MM; Chang KJ; Viveros OH
Neuroscience; 1981; 6(1):71-9. PubMed ID: 6111764
[No Abstract] [Full Text] [Related]
14. 2, 2'- and 4, 4'-Cyanines are transporter-independent in vitro dopaminergic toxins with the specificity and mechanism of toxicity similar to MPP⁺.
Kadigamuwa CC; Le VQ; Wimalasena K
J Neurochem; 2015 Nov; 135(4):755-67. PubMed ID: 26094622
[TBL] [Abstract][Full Text] [Related]
15. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
Staal RG; Hogan KA; Liang CL; German DC; Sonsalla PK
J Pharmacol Exp Ther; 2000 May; 293(2):329-35. PubMed ID: 10772999
[TBL] [Abstract][Full Text] [Related]
16. Role of lipoamide dehydrogenase and metallothionein on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity.
Dhanasekaran M; Albano CB; Pellet L; Karuppagounder SS; Uthayathas S; Suppiramaniam V; Brown-Borg H; Ebadi M
Neurochem Res; 2008 Jun; 33(6):980-4. PubMed ID: 17768676
[TBL] [Abstract][Full Text] [Related]
17. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B.
Ito T; Suzuki K; Uchida K; Nakayama H
Exp Toxicol Pathol; 2012 Nov; 64(7-8):761-5. PubMed ID: 21324658
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine-hydroxylase immunoreactive cells in the rat striatum following treatment with MPP+.
O'Byrne MB; Bolam JP; Hanley JJ; Tipton KF
Adv Exp Med Biol; 2000; 483():369-74. PubMed ID: 11787621
[TBL] [Abstract][Full Text] [Related]
19. Does thioredoxin-1 prevent mitochondria- and endoplasmic reticulum-mediated neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine?
Bai J; Nakamura H; Kwon YW; Tanito M; Ueda S; Tanaka T; Hattori I; Ban S; Momoi T; Kitao Y; Ogawa S; Yodoi J
Antioxid Redox Signal; 2007 May; 9(5):603-8. PubMed ID: 17465883
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of 1-methyl-4-phenylpyridinium (MPP+) into bovine chromaffin granules results in a large restriction of its molecular motion: a 13C and 31P NMR study.
Daniels AJ; Reinhard JF; Painter GR
Biochem Biophys Res Commun; 1988 Nov; 156(3):1243-9. PubMed ID: 3263856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
